Journal for ImmunoTherapy of Cancer (Nov 2021)
Dendritic cell vaccines targeting tumor blood vessel antigens in combination with dasatinib induce therapeutic immune responses in patients with checkpoint-refractory advanced melanoma
- Yan Lin,
- Lisa H Butterfield,
- Pawel Kalinski,
- Walter J Storkus,
- Hussein Tawbi,
- Ahmad Tarhini,
- John M Kirkwood,
- Ronald J Fecek,
- Fei Ding,
- Lauren Miller,
- Deena Maurer,
- Manoj Chelvanambi,
- Amy Rose,
- Jennifer L Taylor,
- Anamika Bose,
- Devin Lowe,
- Melissa DeMark,
- Lilit Karapetyan,
- Jessica N Filderman,
- Timothy J Looney,
- Elizabeth Linch,
- Geoffrey M Lowman
Affiliations
- Yan Lin
- Biostatistics, University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania, USA
- Lisa H Butterfield
- Research and Development, Parker Institute for Cancer Immunotherapy, San Francisco, California, USA
- Pawel Kalinski
- Medical Oncology and Immunology, Roswell Park Cancer Institute, Buffalo, New York, USA
- Walter J Storkus
- Dermatology and Immunology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA
- Hussein Tawbi
- Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA
- Ahmad Tarhini
- Cutaneous Oncology and Immunology, Moffitt Cancer Center, Tampa, Florida, USA
- John M Kirkwood
- Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
- Ronald J Fecek
- Microbiology and Immunology, LECOM, Greensburg, Pennsylvania, USA
- Fei Ding
- Biostatistics, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA
- Lauren Miller
- Molecular Biology, Thermo Fisher Scientific, Santa Clara, Carlsbad, California, USA
- Deena Maurer
- Translational and Regulatory Affairs, Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA
- Manoj Chelvanambi
- Immunology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA
- Amy Rose
- Clinical Research Services, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA
- Jennifer L Taylor
- Dermatology and Immunology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA
- Anamika Bose
- Immunoregulation and Immunodiagnostics, Chittaranjan National Cancer Institute, Kolkata, West Bengal, India
- Devin Lowe
- Immunotherapeutics and Biotechnology, Texas Tech University Health Sciences Center, Abilene, Texas, USA
- Melissa DeMark
- Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA
- Lilit Karapetyan
- Medicine, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA
- Jessica N Filderman
- Immunology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA
- Timothy J Looney
- Immunology, Singular Genomics, Austin, Texas, USA
- Elizabeth Linch
- Molecular Biology, Thermo Fisher Scientific, Santa Clara, Carlsbad, California, USA
- Geoffrey M Lowman
- Molecular Biology, Thermo Fisher Scientific, Santa Clara, Carlsbad, California, USA
- DOI
- https://doi.org/10.1136/jitc-2021-003675
- Journal volume & issue
-
Vol. 9,
no. 11
Abstract
No abstracts available.